Dartisla ODT Dosage

Generic name: GLYCOPYRROLATE 1.7mg
Dosage form: orally disintegrating tablets
Drug class: Anticholinergics / antispasmodics

Medically reviewed by Drugs.com. Last updated on Oct 19, 2023.

Important Dosing Information

Patients receiving the 1 mg dosage strength of another oral tablet dosage form of glycopyrrolate may be switched to the 0.85 mg dosage strength of DARTISLA ODT.
Patients receiving the 2 mg dosage strength of another oral tablet dosage form of glycopyrrolate may be switched to the 1.7 mg dosage strength of DARTISLA ODT.

Recommended Dosage

Initial dosage:

• The recommended initial dosage is 0.85 mg orally three times daily (in the morning, early afternoon, and at bedtime).
• Some patients may require 1.7 mg at bedtime to assure overnight control of symptoms.
• For maintenance, a dosage of 0.85 mg orally twice is frequently adequate.

Dosage for patients switching from 2 mg glycopyrrolate products:

• The recommended dosage is 1.7 mg two or three times daily at equally spaced intervals.

• The maximum recommended daily dosage is 6.8 mg.
• Use the lowest effective dosage to control symptoms.

Administration Instructions

Administer DARTISLA ODT at least one hour before or two hours after food.
Use dry hands when opening the blister card and do not open the blister until ready to administer.
Open the package and peel back the foil on the blister to expose the tablet and gently remove from the blister. Do not push the tablet through the foil.
Do not break or cut the tablet.
Immediately place the tablet on the tongue, allow it to disintegrate, and swallow without water.